Amgen Stock Hits Day High with Strong 4.48% Intraday Surge

Amgen, Inc., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable surge in its stock performance, gaining 4.48% on July 28, 2026. The stock reached an intraday high of USD 397.89, reflecting strong market activity. Over the past week, Amgen has outperformed the S&P 500, with a 7.33% increase compared to the index's decline of 1.07%. In the past month, Amgen's stock has risen by 9.7%, while the S&P 500 managed only a modest gain of 1.02%. Over the last year, Amgen has delivered an impressive return of 30.47%, significantly surpassing the S&P 500's 16.26%. The company's year-to-date performance stands at 20.1%, compared to the S&P 500's 8.52%. Amgen's strong financial metrics include a high return on capital employed (ROCE) of 22.31% and a robust dividend payout ratio of 75.36%. The company has also seen a decrease in raw material costs by 7.96% year-over-year, contributing to its solid financial standing. With institutional holdings at 83.15%, Amgen continues to demonstrate its strong market position and operational efficiency.